Literature DB >> 30217673

Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer.

Giandomenico Roviello1, Daniele Generali2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30217673     DOI: 10.1016/S1470-2045(18)30512-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer.

Authors:  Xiaodong Huang; Jie Zhang; Yongbin Zheng
Journal:  Front Mol Biosci       Date:  2020-12-15

2.  CircPTK2 Suppresses the Progression of Gastric Cancer by Targeting the MiR-196a-3p/AATK Axis.

Authors:  Ling Gao; Tingting Xia; Mingde Qin; Xiaofeng Xue; Linhua Jiang; Xinguo Zhu
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.